Pramod John, PhD, CEO, VIVIO Health, San Leandro, CA; Email: pramod@viviohealth.com Q: Some American pharmaceutical companies are well-known for pricing drugs at “whatever the market will bear”. In oncology, some […]
Eddy Yang, MD, PhD, Professor and Vice Chair of Translational Sciences Department of Radiation Oncology; Deputy Director, Associate Director of Precision Oncology at the Hugh Kaul Precision Medicine Institute; Birmingham, AL; […]
Justin Stebbing, MA FRCP FRCPath PhD, Professor of Cancer Medicine and Medical Oncology at the Imperial College/Imperial Healthcare NHS Trust Charing Cross Hospital, London, UK; Email: j.stebbing@imperial.ac.uk Q: Science is […]
Lisandra West-Odell, PhD, Scientist and Product Manager, Cancer Commons, Los Altos, CA; Email: lisandra@cancercommons.org Q: Reflecting the current reality of a brain cancer diagnosis, how can Cancer Commonspositively impact the treatment […]
Professor Michael Baum, Professor Emeritus of Surgery & Visiting Professor of Medical Humanities, University College, London, UK; Email: baum.michael3@gmail.com Q: You have recently decided to “withdraw from the field” after […]
Erin Maloney, Intrepid explorer, Amateur photographer, Aspiring leader; Toronto, ON; Email: erinLmaloney@gmail.com Q: You have recently disclosed that you have had a diagnosis of cancer and described your experience in […]
Charlotte J. Haug, MD, PhD, MSc, International Correspondent, New England Journal of Medicine; Senior Scientist, SINTEF Techology and Society; Adjunct Affiliate, Stanford Health Policy; Oslo, Norway; Email: charlottejohanne@gmail.com Q: Many people are coming […]
Joel L. Nitzkin, MD, Public Health Physician, New Orleans, LA Email: jlnitzkin@gmail.com Q: Tobacco smoking remains the most preventable primary form of cancer causation in Americans. A recent Medscape column urged that […]
Saeed K. Alzghari, M.S., M.B.A. (HOM), Pharm.D., BCPS, Director of Clinical Pharmacy, Gulfstream Genomics, LLC., Dallas, TX; Email: salzghari@gulfdiagnostics.com Q: Proper use of Pharmacogenomics can inform better patient care in […]
Gualberto Ruaño, MD, PhD, President, Genomas Inc.; Medical Director, Laboratory of Personalized Health; Hartford, CT; Email: g.ruano@genomas.net Q: Public participation by contributing specimens to assess personal genomic information is rapidly increasing. […]